首页|培哚普利吲达帕胺联合硝苯地平治疗单药治疗未达标高血压患者的效果及安全性分析

培哚普利吲达帕胺联合硝苯地平治疗单药治疗未达标高血压患者的效果及安全性分析

扫码查看
目的:探究和分析单药治疗未达标高血压患者应用培哚普利吲达帕胺联合硝苯地平治疗的效果和安全性。方法:选择 2022 年 1-12 月黄河三门峡医院收治的 60 例单药治疗未达标高血压患者作为研究对象,采用单双号法分组,将单号者纳入对照组,双号者纳入观察组,各 30 例。对照组采用阿利沙坦酯联合硝苯地平治疗,观察组采用培哚普利吲达帕胺联合硝苯地平治疗。比较两组治疗前后的舒张压、收缩压、舒张压平滑指数、收缩压平滑指数、不良反应发生率及血压达标率。结果:治疗前,两组舒张压、收缩压、舒张压平滑指数、收缩压平滑指数比较,差异无统计学意义(P>0。05);治疗后,观察组舒张压、收缩压低于对照组,观察组舒张压平滑指数、收缩压平滑指数高于对照组,差异有统计学意义(P<0。05)。观察组不良反应发生率低于对照组,血压达标率高于对照组,差异有统计学意义(P<0。05)。结论:应用培哚普利吲达帕胺联合硝苯地平治疗单药治疗未达标高血压患者的效果和安全性均较高。
Efficacy and Safety Analysis of Perindopril and Indapamide Combined with Nifedipine in the Treatment of Non-standard Hypertension Patients treated with Monotherapy
Objective:To explore and analyze the efficacy and safety of Perindopril and Indapamide combined with Nifedipine in the treatment of non-standard hypertension patients treated with monotherapy.Method:A total of 60 non-standard hypertension patients treated with monotherapy treatment treated in Yellow River Sanmenxia Hospital from January to December 2022 were selected as the study objects.The group was divided by odd-even number method,and those with single number were included in the control group,and those with even number were included in the observation group,with 30 cases in each group.The control group was treated with Allisartan Isoproxil combined with Nifedipine,and the observation group was treated with Perindopril and Indapamide combined with Nifedipine.The diastolic blood pressure,systolic blood pressure,diastolic blood pressure smoothing index,systolic blood pressure smoothing index before and after treatment,the incidence of adverse reactions and the rate of blood pressure reaching the standard were compared between the two groups.Result:Before treatment,there were no significant differences in the diastolic blood pressure,systolic blood pressure,diastolic blood pressure smoothing index and systolic blood pressure smoothing index between the two groups(P>0.05).After treatment,the diastolic blood pressure and systolic blood pressure of the observation group were lower than those of the control group,and the diastolic blood pressure smoothing index and systolic blood pressure smoothing index were higher than those of the control group,the differences were statistically significant(P<0.05).The incidence of adverse reactions in the observation group was lower than that in the control group,and the blood pressure compliance rate was higher than that in the control group,the differences were statistically significant(P<0.05).Conclusion:Perindopril and Indapamide combined with Nifedipine are effective and safe in the treatment of non-standard hypertension patients treated with monotherapy.

Perindopril and IndapamideNifedipineMonotherapyNon-standardHypertension

陈鹏

展开 >

黄河三门峡医院 河南 三门峡 472000

培哚普利吲达帕胺 硝苯地平 单药治疗 未达标 高血压

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(3)
  • 13